Publicaciones (43) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. BZ-97: A Promising Compound Against Trypanosoma cruzi

    Current Trends in Biotechnology and Pharmacy, Vol. 18, Núm. 2, pp. 1745-1764

  2. Barriers and facilitators of health professionals in adopting digital health-related tools for medication appropriateness: A systematic review

    Digital Health, Vol. 10

  3. Bee Venom-Loaded Niosomes as Innovative Platforms for Cancer Treatment: Development and Therapeutical Efficacy and Safety Evaluation

    Pharmaceuticals, Vol. 17, Núm. 5

  4. Bioguided Assay of Polyphenols Isolated from Medicinal Mayan Species and its Activity Against Leishmania mexicana

    Pharmacognosy Journal, Vol. 16, Núm. 1, pp. 174-180

  5. Chemical and Bioactive Properties of Red Rice with Potential Pharmaceutical Use

    Molecules, Vol. 29, Núm. 10

  6. Chronic sarpogrelate treatment improves renal sympathetic hyperactivity in experimental diabetes

    Biomedicine and Pharmacotherapy, Vol. 176

  7. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

    Therapeutic Advances in Gastroenterology, Vol. 17

  8. Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 18, Núm. 1, pp. 65-74

  9. Comparing AGS Beers 2019, STOPP version 2, and EU(7)-PIM list in Portuguese older adults in primary health care

    European Journal of Clinical Pharmacology, Vol. 80, Núm. 4, pp. 603-612

  10. Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study

    United European Gastroenterology Journal

  11. Constrained numerical deconvolution using orthogonal polynomials

    Heliyon, Vol. 10, Núm. 3

  12. Current drug strategies for the treatment and control of schistosomiasis

    Expert Opinion on Pharmacotherapy, Vol. 25, Núm. 4, pp. 409-420

  13. Cytotoxic Cyclolignans Obtained by the Enlargement of the Cyclolignan Skeleton of Podophyllic Aldehyde, a Selective Podophyllotoxin-Derived Cyclolignan

    Molecules, Vol. 29, Núm. 7

  14. Digital Twin of Calais Canal with Model Predictive Controller: A Simulation on a Real Database

    Journal of Water Resources Planning and Management, Vol. 150, Núm. 5

  15. Discrepancies in Electronic Medical Prescriptions Found in a Hospital Emergency Department: A Prospective Observational Study

    Pharmaceuticals, Vol. 17, Núm. 4

  16. Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis

    Frontiers in Pharmacology, Vol. 15

  17. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

    Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 10, pp. 1248-1259

  18. Effects of Electron Beam Radiation on the Phenolic Composition and Bioactive Properties of Olive Pomace Extracts

    Antioxidants, Vol. 13, Núm. 5

  19. Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift?

    Medicinal Research Reviews, Vol. 44, Núm. 3, pp. 1055-1120

  20. Exploring Propolis as a Sustainable Bio-Preservative Agent to Control Foodborne Pathogens in Vacuum-Packed Cooked Ham

    Microorganisms, Vol. 12, Núm. 5